Target Name: TRPV6
NCBI ID: G55503
Review Report on TRPV6 Target / Biomarker Content of Review Report on TRPV6 Target / Biomarker
TRPV6
Other Name(s): calcium transporter-like protein | ABP/ZF | HRPTTN | ECaC2 | TrpV6 | CaT-like | LP6728 | Calcium transporter-like protein | CaT1 | Epithelial calcium channel 2 | epithelial apical membrane calcium transporter/channel CaT1 | ECAC2 | TRPV6_HUMAN | CAT1 | Calcium transport protein 1 | CaT-L | calcium transport protein 1 | CATL | ZFAB | Transient receptor potential cation channel subfamily V member 6 | Alu-binding protein with zinc finger domain | transient receptor potential cation channel subfamily V member 6 | epithelial calcium channel 2 | Epithelial apical membrane calcium transporter/channel CaT1 | HSA277909

TRPV6: A Calcium Transporter-Like Protein as a Drug Target and Biomarker

Calcium homeostasis plays a crucial role in various physiological processes, including muscle contractions, nerve function, and brain activity. The regulation of calcium levels is critical for maintaining neuronal excitability and tissue function. However, when calcium levels become imbalanced or excessive, it can lead to neuronal excitability disorders, muscle spasms, and other debilitating conditions. One of the known proteins involved in regulating calcium homeostasis is TRPV6 (Transient receptor potential cation channel subfamily 6), a calcium transporter-like protein that has been identified as a potential drug target and biomarker for various neurological and psychiatric disorders.

TRPV6: Structure and Function

TRPV6 is a member of the Transient receptor potential cation channel subfamily 6, which is a family of calcium channels that play a crucial role in sensory and neural signaling. The TRPV6 gene was first identified in 2001 and has been expressed in many different tissues and organs, including brain, heart, skeletal muscles, and tissues. TRPV6 is known for its ability to regulate calcium homeostasis, which is critical for maintaining neuronal excitability and tissue function.

TRPV6 is a 23-kDa protein that consists of an N-terminus, a unique topology region, a catalytic domain, and a C-terminus. The N-terminus of TRPV6 contains a short peptide that is involved in the formation of the N-terminal region of TRPV6. The unique topology region is located between the N-terminus and the catalytic domain, and it contains a putative N-terminal ion channel that is involved in the regulation of calcium homeostasis.

TRPV6 functions as a calcium transporter, allowing it to regulate the movement of calcium ions into and out of cells. This process is critical for maintaining neuronal excitability and tissue function. TRPV6 is also known for its role in modulating pain perception and anxiety regulation.

TRPV6 as a Drug Target

TRPV6 has been identified as a potential drug target for various neurological and psychiatric disorders. Its ability to regulate calcium homeostasis and its role in modulating pain perception and anxiety regulation make it an attractive target for small molecule inhibitors. Several studies have shown that TRPV6 is involved in the regulation of pain perception, anxiety regulation, and other neurological disorders.

One of the most promising strategies for targeting TRPV6 is the use of small molecules that can inhibit its function. Drugs that can inhibit TRPV6 function have been shown to be effective in treating various neurological and psychiatric disorders, including pain, anxiety, and depression.

TRPV6 as a Biomarker

TRPV6 has also been identified as a potential biomarker for various neurological and psychiatric disorders. Its regulation of calcium homeostasis is closely linked to the regulation of neuronal excitability and tissue function. Therefore, changes in TRPV6 function can be indicative of alterations in neuronal excitability and tissue function.

Several studies have shown that TRPV6 levels are regulated by various factors, including pain, anxiety, and depression. Additionally, changes in TRPV6 function have been observed in various neurological disorders, including Alzheimer's disease, Parkinson's disease, and epilepsy. These findings suggest that TRPV6 may be a useful biomarker for assessing the severity and progression of these disorders.

Conclusion

In conclusion, TRPV6 is a highly promising protein that has been identified as a potential drug target and biomarker for various neurological and psychiatric disorders. Its ability to regulate calcium homeostasis and its role in modulating pain perception and anxiety regulation make it an attractive target for small molecule inhibitors. Further research is needed to fully understand the

Protein Name: Transient Receptor Potential Cation Channel Subfamily V Member 6

Functions: Calcium selective cation channel that mediates Ca(2+) uptake in various tissues, including the intestine (PubMed:11097838, PubMed:11278579, PubMed:11248124, PubMed:15184369, PubMed:23612980, PubMed:29258289). Important for normal Ca(2+) ion homeostasis in the body, including bone and skin (By similarity). The channel is activated by low internal calcium level, probably including intracellular calcium store depletion, and the current exhibits an inward rectification (PubMed:15184369). Inactivation includes both a rapid Ca(2+)-dependent and a slower Ca(2+)-calmodulin-dependent mechanism; the latter may be regulated by phosphorylation. In vitro, is slowly inhibited by Mg(2+) in a voltage-independent manner. Heteromeric assembly with TRPV5 seems to modify channel properties. TRPV5-TRPV6 heteromultimeric concatemers exhibit voltage-dependent gating

The "TRPV6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TRPV6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

TRR-ACG1-2 | TRRAP | TRU-TCA2-1 | TRUB1 | TRUB2 | Trypanosome lytic factor 1 | Trypanosome lytic factor 2 | Trypsin | Tryptase | Tryptophan 5-Monooxygenase | TSACC | TSBP1 | TSBP1-AS1 | TSC1 | TSC2 | TSC22D1 | TSC22D1-AS1 | TSC22D2 | TSC22D3 | TSC22D4 | TSEN15 | TSEN2 | TSEN2P1 | TSEN34 | TSEN54 | TSFM | TSG1 | TSG101 | TSGA10 | TSGA10IP | TSGA13 | TSHB | TSHR | TSHZ1 | TSHZ2 | TSHZ3 | TSHZ3-AS1 | TSIX | TSKS | TSKU | TSLP | TSN | TSNARE1 | TSNAX | TSNAX-DISC1 | TSNAXIP1 | TSPAN1 | TSPAN10 | TSPAN11 | TSPAN12 | TSPAN13 | TSPAN14 | TSPAN15 | TSPAN16 | TSPAN17 | TSPAN18 | TSPAN19 | TSPAN2 | TSPAN3 | TSPAN31 | TSPAN32 | TSPAN33 | TSPAN4 | TSPAN5 | TSPAN6 | TSPAN7 | TSPAN8 | TSPAN9 | TSPEAR | TSPEAR-AS1 | TSPEAR-AS2 | TSPO | TSPO2 | TSPOAP1 | TSPOAP1-AS1 | TSPY1 | TSPY2 | TSPY26P | TSPY3 | TSPY4 | TSPYL1 | TSPYL2 | TSPYL4 | TSPYL5 | TSPYL6 | TSR1 | TSR2 | TSR3 | TSSC2 | TSSC4 | TSSK1B | TSSK2 | TSSK3 | TSSK4 | TSSK6 | TST | TSTD1 | TSTD2 | TSTD3 | TTBK1